Composition
- Active ingredients
- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 0.398GM; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 1.102GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA021892.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Osmoprep
- Active substance
- sodium phosphate, dibasic, anhydrous
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Salix Pharms
- Status
- Discontinued
- FDA approval
- 16 Mar 2006
- Application
- NDA021892-001